Visterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.
Description
Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America